Familial Hypercholesterolaemia
7
3
4
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Specified Drug-use Survey of Leqvio for s.c. Injection.
Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia
Cardiovascular Risk in Children With Chronic Conditions Study
The Spanish Familial Hypercholesterolaemia Cohort Study
Pilot Project of Familial Hypercholesterolemia Screening in Newborns in the Czech Republic
An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia
Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils